ACE and hydrops fetalis: Use of angiotensin converting enzyme inhibitors (ACEi), angiotensin receptor blocker (ARB), beta-blockers, mineralocorticoid antagonists (MRA), and diuretics were more frequent in patients with HF (groups 3 and 4) compared to those without HF (groups 1 and 2), but were not different according to the use of SGLT2i (groups 1 vs. 2; groups 3 vs. 4).